Cryo-Cell International (FRA:ZCY) Other Current Liabilities: €-0.00 Mil (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ZCY Cryo-Cell International Inc FRA:ZCY
53 GF Score
Price €2.82
GF Value €4.67
! 4 Warning Signs
View Full Analysis

What is Cryo-Cell International Other Current Liabilities?

Cryo-Cell International FRA:ZCY -0.70% 53 Other Current Liabilities is €-0.00 Mil as of May. 2026. GuruFocus rates FRA:ZCY with a GF Score™ of 53/100 and a GF Value™ of €4.67. The stock has 4 warning signs investors should review.

Cryo-Cell International's other current liabilities for the quarter that ended in May. 2026 was €-0.00 Mil.

Cryo-Cell International's quarterly other current liabilities increased from Nov. 2025 (€-0.00 Mil) to Feb. 2026 (€0.00 Mil) but then declined from Feb. 2026 (€0.00 Mil) to May. 2026 (€-0.00 Mil).

Cryo-Cell International's annual other current liabilities declined from Nov. 2023 (€1.11 Mil) to Nov. 2024 (€0.00 Mil) and declined from Nov. 2024 (€0.00 Mil) to Nov. 2025 (€-0.00 Mil).

Cryo-Cell International Other Current Liabilities Related Terms

Cryo-Cell International Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Cryo-Cell International's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryo-Cell International Other Current Liabilities Chart

Cryo-Cell International Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.34 1.95 1.11 0.00 -0.00

Cryo-Cell International Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 -0.00 0.00 -0.00
FRA:ZCY
53GF Score
Cryo-Cell International Inc FRA:ZCY
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cryo-Cell International Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €-0.00 Mil mean?
Cryo-Cell International (FRA:ZCY) has a Other Current Liabilities of €-0.00 Mil as of May. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Cryo-Cell International.
Is Cryo-Cell International's Other Current Liabilities too high?
Cryo-Cell International's current Other Current Liabilities is €-0.00 Mil. Overall, Cryo-Cell International has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Cryo-Cell International's Other Current Liabilities compare to EHSI and PIII?
Cryo-Cell International's Other Current Liabilities of €-0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Healthcare Providers & Services company?
A good Other Current Liabilities depends on the Healthcare Providers & Services industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Cryo-Cell International. Cryo-Cell International's current Other Current Liabilities is €-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryo-Cell International stock overvalued right now?
Cryo-Cell International (FRA:ZCY) has a current Other Current Liabilities of €-0.00 Mil. The stock's GF Value™ is €4.67, compared to a current price of €2.82 — trading 39.6% below its estimated fair value. The current Other Current Liabilities is €-0.00 Mil. Cryo-Cell International's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Cryo-Cell International (FRA:ZCY), the current Other Current Liabilities is €-0.00 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cryo-Cell International (FRA:ZCY) Overvalued in 2026?

Based on GuruFocus' analysis, Cryo-Cell International stock appears to be undervalued. The current stock price of €2.82 is trading 39.6% below its estimated GF Value™ of €4.67.

Key valuation signals for FRA:ZCY:

  • Other Current Liabilities: €-0.00 Mil
  • GF Value™: €4.67 vs. price of €2.82 (39.6% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the FRA:ZCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cryo-Cell International Business Description

Other Exchanges CCEL:USA
Address 700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
53GF Score

Get the complete analysis for FRA:ZCY

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.82
Price
€4.67
GF Value